Brief: Cynata Therapeutics Posts FY Net Loss Attributable Of A$14.3 Million
28/08/2023 12:11
Aug 28 (Reuters) - Cynata Therapeutics Ltd CYP.AX :
* FY NET LOSS ATTRIBUTABLE A$14.3 MILLION VERSUS LOSS A$5.4
MILLION
* FY REVENUE FROM ORDINARY ACTIVITIES A$2 MILLION VERSUS
A$7.8
MILLION
Source text for Eikon: ID:nASX78vr1s
Further company coverage: CYP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cynata Therapeutics
See all newsBrief: Cynata Therapeutics Says Firm Commitments Received To Raise Further A$550,000 Via Placement
Brief: Cynata Therapeutics Enters Consultancy Agreement With LIR Bio Advisory
Brief: Cynata Therapeutics Establishes Share Sale Facility For Unmarketable Parcel Holders
Brief: Cynata Therapeutics Terminates Of At-The-Market Subscription Deed
Brief: Cynata Therapeutics Posts FY2026 Loss From Ordinary Activities After Tax A$9.1 Million